This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Eisai R&D Management Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kenzo Arai: Innovator in Cancer Treatment
Introduction
Kenzo Arai is an inventor based in Ibaraki, Japan. He is known for his contributions to the field of pharmaceutical compounds, particularly those aimed at treating cancers. Although he currently holds no granted patents, his innovative work in developing novel compounds shows promise in the medical field.
Latest Patent Applications
Kenzo Arai's latest patent applications include "Certain Pladienolide Compounds and Methods of Use." This disclosure provides novel pladienolide compounds, pharmaceutical compositions containing such compounds, and methods for using the compounds as therapeutic agents. These compounds may be useful in the treatment of cancers, particularly cancers in which agents that target the spliceosome and mutations therein are known to be effective. The application also outlines methods of treating cancers by administering at least one compound disclosed and at least one additional therapy.
Conclusion
Kenzo Arai's work in developing innovative compounds for cancer treatment highlights his potential impact on the pharmaceutical industry. His ongoing research and patent applications may lead to significant advancements in therapeutic options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile